On Holding and LOEWE Unveil LightSpray Cloudmonster A Fusion of Performance and Luxury Monthly Retail Trade Sales Report from Census Bureau Highlights Consumer Spending Trends UK Spy Chief Warns of Moment of Consequence as West Faces Mounting Threats from Russia and China Fed Holds Rates Steady Amid Divided Decision Nvidias 5 Trillion Market Cap Surpasses Six of Worlds Top 10 Stock Markets Amid AI Rally Analysts Identify Adani Power Netweb Technologies and Others for Potential NearTerm Gains Amid Market Weakness Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction NewtekOne Inc 850 Fixed Rate Senior Notes due 2029 NEWTG Q1 2026 Earnings EPS Slightly Misses Estimates Revenue Not Disclosed Serve Robotics Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Stock Declines SCCF Q4 2025 Earnings Massive EPS Surprise of 782 Driven by Strong Operational Performance Gilat Satellite Networks GILT Q1 2026 Earnings Massive EPS Beat Surprises Market Stock Gains American Tower AMT Holds Near Resistance as REIT Sector Seeks Direction Starry Sea Acquisition Corp Rights SSEAR Holds Steady at 017 Amid Thin Trading BRC Inc BRCC Dips Past Key Levels as Volume Increases Pelican Acquisition PELI Shares Tumble 1179 Support Levels in Focus Insulet PODD Holds Steady Near Support as Trading Volume Remains Subdued VTGN Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns HMY Q2 2016 Earnings EPS Miss by 5475 Yet Stock Rallies 716 TriSalus Life Sciences TLSI Q1 2026 Earnings EPS Surges Past Expectations Yet Stock Slips CHCT Q1 2026 Earnings EPS Surges Past Estimates with 449 Beat YJ Q3 2024 Earnings Significant EPS Miss Triggers Stock Decline Understanding Bad Credit Personal Loans Key Information for Borrowers SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally Inhibrx Biosciences INBX Surges Over 5 as Biotech Momentum Builds